Related Experiment Video
Updated: Feb 12, 2026

Control of Eating Behavior Using a Novel Feedback System
Published on: May 8, 2018
Structured education using Dose Adjustment for Normal Eating (DAFNE) reduces long-term HbA1c and HbA1c variability.
G S Walker1, J Y Chen1, H Hopkinson2
1Diabetes Centre, Gartnavel General Hospital, Glasgow, UK.
The Dose Adjustment for Normal Eating (DAFNE) program improves glycemic control in Type 1 diabetes, significantly reducing HbA1c levels and variability for up to five years. This structured education also lowers HbA1c variability, a novel finding with potential health benefits.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Diabetes Management
Background:
- Type 1 diabetes (T1D) management aims to optimize glycemic control and minimize complications.
- Increased HbA1c variability is linked to higher morbidity and mortality in T1D.
- The impact of structured education programs on HbA1c variability in T1D remains underexplored.
Purpose of the Study:
- To assess the long-term effects of the Dose Adjustment for Normal Eating (DAFNE) program on HbA1c levels and variability in individuals with T1D.
- To determine if structured diabetes education can reduce HbA1c variability.
Main Methods:
- Utilized the Scottish Care Information-Diabetes dataset to identify T1D patients who completed the DAFNE program.
- Calculated HbA1c median and variability (coefficient of variation, CV) pre- and post-DAFNE participation.
- Analyzed data from 687 eligible participants.
Main Results:
- DAFNE participation led to a significant reduction in median HbA1c at 12 months (-3.5 mmol/mol) and sustained reduction at 60 months (-1.5 mmol/mol).
- HbA1c variability, measured by CV, significantly decreased post-DAFNE (0.08 to 0.07; P = 0.002).
- This study is the first to demonstrate reduced HbA1c variability following structured diabetes education.
Conclusions:
- The DAFNE program effectively improves and sustains glycemic control in T1D for up to 5 years.
- Structured education, specifically DAFNE, demonstrably reduces HbA1c variability in T1D patients.
- These findings highlight the beneficial impact of DAFNE on the overall glycemic profile in T1D management.
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Binge Eating Disorders
Variation: Normal Distribution, Range, and Standard Deviation
The Anchoring-and-Adjustment Heuristic

